ENG
Vitamin D Therapy Market: Global Industry Analysis and Forecast (2024-2030), Technology Trends
Vitamin D Therapy Market size was valued at US$ 2.96 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 11.9% through 2024 to 2030, reaching nearly US$ 6.51 Bn.
Format : PDF | Report ID : SMR_318
Vitamin D Therapy Market Overview:
Vitamin D is considered an essential nutrient because it is not generated by the human body. Vitamin D is best obtained from direct sunshine. Vitamin D insufficiency is caused by a lack of adequate vitamin D. It is a widespread issue among many people, particularly among the elderly. Vitamin D aids calcium and phosphorus absorption from the small intestine, as well as controlling the release of parathyroid hormones, which can promote bone resorption.
Though vitamin D therapy market forecasting through 2030 is based on real output, demand and supply of 2023, 2023 numbers are also estimated on real numbers published by key players as well all-important players across the world. Market forecasting till 2030 is done based on past data from 2018 to 2022 with the impact of global lock down on the market in 2020 and 2021.
To get more Insights: Request Free Sample Report
Vitamin D Therapy Market Dynamics:
The increased prevalence of osteoporosis had a significant impact on the vitamin D therapy market. The growing number of old persons has also boosted market growth, as the elderly are more susceptible to vitamin D insufficiency than the younger population. The prevalent sedentary lifestyle among individuals of all ages is one of the most prominent causes of vitamin D insufficiency. All of these factors have contributed to an increase in vitamin D deficient cases, necessitating the use of vitamin D therapy. More money is being put into this industry to develop new applications for vitamin D therapy, which will help the business grow even faster.
People are becoming more active and health-conscious as a result of the pandemic, and in attempt to combat the COVID-19 virus, people are becoming more active and health-conscious. As healthcare spending has increased in emerging countries such as India, Bangladesh, and Thailand, the Vitamin D Therapy Market has emerged as a growth opportunity. Another factor driving market growth is the growing practice of food fortification to promote items that are enhanced with needed nutrients.
The number of mergers and acquisitions is rising
During the forecast period, an increase in the number of mergers and acquisitions is expected to drives the vitamin D therapy market growth. For example, in February 2020, Solmic's technology increased the bioavailability of water insoluble chemicals like CBD by up to 15 times, paving the way for Betterlife's acquisition. Betterlife, a manufacturer of pharmaceutical-grade products, announced the acquisition of Solmic, a Swiss company, in order to gain access to the latter's formulation technology for orally given Cannabidiol-based (CBD) products.
According to Betterlife, Solmic's technology is based on a 15-fold increase in the creation of stable micelles containing water-soluble substances, allowing for quicker reception of the contents in the human digestive tract.
Vitamin D Therapy Market Segment Analysis:
Based on the Route of Administration, the market is segmented into Oral Route, and Parenteral Route. Oral Route of Administration segment is expected to hold the largest market shares of xx% by 2030. The Vitamin D Therapy market is driven by the convenience of administration, safety, efficiency, and lower chances of toxicity paired with patient compliance, as well as a preference for the oral route due to availability in various forms such as chewing gums and tablets. These are the factors that are expected to drives the growth of the Oral Route of Administration segment in the Vitamin D Therapy market during the forecast period 2024-2030.
Based on the Purchasing Pattern, the market is segmented into OTC Drugs, and Prescription Drugs. Prescription Drugs segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. Prescription drugs account for the highest share of purchases, owing to the preference for diagnosis by qualified medical practitioners and prescribed therapy with appropriate prescriptions. Besides, the higher cost of prescription drugs than over-the-counter drugs is expected to drive the global vitamin D therapy market during the forecast period.
Based on the Application, the market is segmented into Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders, and Other Applications. Osteoporosis segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. This is due to the growing ageing population, an increase in the incidence of falls and fractures, elevated
levels of parathyroid hormones, and poor calcium absorption from their diets, necessitating Vitamin D therapy to improve calcium absorption.
Vitamin D Therapy Market Regional Insights:
North America region is expected to dominate the Vitamin D Therapy market during the forecast period 2024-2030. North America region is expected to hold the largest market shares of xx% by 2030. This is due to the presence of leading players based in the United States, as well as a focus on research activities to develop more patient-friendly products with improved efficiency, as well as government support and rising healthcare expenditure, all of which contribute to the market's outstanding revenue share in the vitamin D therapy market.
Asia Pacific region is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. Sedentary lifestyles, a large target patient pool due to the heavy population in developing countries like India and China, and increased air pollution are all factors contributing to the region's tremendous growth. An increase in vitamin D deficiency awareness initiatives by governments and businesses in growing economies in the region is also expected to drive vitamin D therapy market growth, increasing global market revenue.
The objective of the report is to present a comprehensive analysis of the Vitamin D Therapy Market to the stakeholders in the industry. The report provides trends that are most dominant in the Vitamin D Therapy Market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players
The qualitative and quantitative data provided in the Vitamin D Therapy Market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Vitamin D Therapy Market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the market.
The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals are existing, who they are, and how their product quality is in the Market. The report also analyses if the Vitamin D Therapy Market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly if the market is dominated by a few players, etc.
The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the Market. Economic variables aid in the analysis of economic performance drivers that have an impact on the Market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the Vitamin D Therapy Market is aided by legal factors.
Vitamin D Therapy Market Scope:
|
Vitamin D Therapy Market |
|
|
Market Size in 2023 |
USD 2.96 Bn. |
|
Market Size in 2030 |
USD 6.51 Bn. |
|
CAGR (2024-2030) |
11.9% |
|
Historic Data |
2018-2022 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2030 |
|
Segment Scope |
By Route of Administration
|
|
By Purchasing Pattern
|
|
|
By Application
|
|
|
By Age Group
|
|
|
Regional Scope |
North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America |
Vitamin D Therapy Market Key Players
- Abbott (US)
- Sanofi (France)
- GlaxoSmithKline plc (UK)
- Pfizer Inc. (US)
- Merck & Co., Inc. (US)
- Torrent Pharmaceuticals Ltd. (India)
- Novartis International AG (Switzerland)
- Alkem Laboratories (India)
- Sun Pharmaceutical Industries Ltd. (India
- Cadila Healthcare Ltd (India)
- AIE Pharmaceuticals (Canada)
- Tru Body Wellness (Canada)
- Matsun Nutrition (California)
- NewGen Pharma (California)
Frequently Asked Questions
North America is expected to hold the highest share in the Vitamin D Therapy Market.
Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), and Merck & Co., Inc. (US) are the top key players in the Vitamin D Therapy Market.
Oral Route of Administration segment hold the largest market share in the Vitamin D Therapy market by 2030.
The market size of the Vitamin D Therapy market is expected to reach US $ 6.51 Bn. by 2030.
The market size of the Vitamin D Therapy market was worth US $ 2.96 Bn. in 2023.
1. Vitamin D Therapy Market: Research Methodology
1.1. Research Data
1.1.1. Primary Data
1.1.2. Secondary Data
1.2. Market Size Estimation
1.2.1. Bottom-Up Approach
1.2.2. Top-Down Approach
1.3. Market Breakdown and Data Triangulation
1.4. Research Assumptions
2. Vitamin D Therapy Market: Executive Summary
2.1. Market Overview
2.2. Market Size (2023) and Forecast (2024 – 2030) and Y-O-Y%
2.3. Market Size (USD) and Market Share (%) – By Segments and Regions
3. Vitamin D Therapy Market: Competitive Landscape
3.1. Stellar Competition Matrix
3.2. Key Players Benchmarking
3.2.1. Company Name
3.2.2. Headquarter
3.2.3. Business Segment
3.2.4. End-user Segment
3.2.5. Y-O-Y%
3.2.6. Revenue (2023)
3.2.7. Profit Margin
3.2.8. Market Share
3.2.9. Company Locations
3.3. Market Structure
3.3.1. Market Leaders
3.3.2. Market Followers
3.3.3. Emerging Players
3.4. Consolidation of the Market
3.4.1. Strategic Initiatives and Developments
3.4.2. Mergers and Acquisitions
3.4.3. Collaborations and Partnerships
3.4.4. Product Launches and Innovations
4. Vitamin D Therapy Market: Dynamics
4.1. Market Trends by Region
4.1.1. North America
4.1.2. Europe
4.1.3. Asia Pacific
4.1.4. Middle East and Africa
4.1.5. South America
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Market Challenges
4.6. PORTER’s Five Forces Analysis
4.6.1. Intensity of the Rivalry
4.6.2. Threat of New Entrants
4.6.3. Bargaining Power of Suppliers
4.6.4. Bargaining Power of Buyers
4.6.5. Threat of Substitutes
4.7. PESTLE Analysis
4.7.1. Political Factors
4.7.2. Economic Factors
4.7.3. Social Factors
4.7.4. Technological Factors
4.7.5. Legal Factors
4.7.6. Environmental Factors
4.8. Technological Roadmap
4.9. Regulatory Landscape
4.9.1. Market Regulation by Region
4.9.1.1. North America
4.9.1.2. Europe
4.9.1.3. Asia Pacific
4.9.1.4. Middle East and Africa
4.9.1.5. South America
4.9.2. Impact of Regulations on Market Dynamics
4.9.3. Government Schemes and Initiatives
5. Vitamin D Therapy Market Size and Forecast by Segments (by Value USD Million)
5.1. Vitamin D Therapy Market Size and Forecast, By Route of Administration (2023-2030)
5.1.1. Oral Route
5.1.2. Parenteral Route
5.2. Vitamin D Therapy Market Size and Forecast, By Purchasing Pattern (2023-2030)
5.2.1. OTC Drugs
5.2.2. Prescription Drugs
5.3. Vitamin D Therapy Market Size and Forecast, By Application (2023-2030)
5.3.1. Osteoporosis
5.3.2. Rickets
5.3.3. Skin Diseases
5.3.4. Muscle Weakness
5.3.5. Autoimmune Disorders
5.3.6. Other Applications
5.4. Vitamin D Therapy Market Size and Forecast, By Age Group (2023-2030)
5.4.1. Children
5.4.2. Adult
5.4.3. Senior Adult
5.5. Vitamin D Therapy Market Size and Forecast, by Region (2023-2030)
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Middle East and Africa
5.5.5. South America
6. North America Vitamin D Therapy Market Size and Forecast (by Value USD Million)
6.1. North America Vitamin D Therapy Market Size and Forecast, By Route of Administration (2023-2030)
6.1.1. Oral Route
6.1.2. Parenteral Route
6.2. North America Vitamin D Therapy Market Size and Forecast, By Purchasing Pattern (2023-2030)
6.2.1. OTC Drugs
6.2.2. Prescription Drugs
6.3. North America Vitamin D Therapy Market Size and Forecast, By Application (2023-2030)
6.3.1. Osteoporosis
6.3.2. Rickets
6.3.3. Skin Diseases
6.3.4. Muscle Weakness
6.3.5. Autoimmune Disorders
6.3.6. Other Applications
6.4. North America Vitamin D Therapy Market Size and Forecast, By Age Group (2023-2030)
6.4.1. Children
6.4.2. Adult
6.4.3. Senior Adult
6.5. North America Vitamin D Therapy Market Size and Forecast, by Country (2023-2030)
6.5.1. United States
6.5.2. Canada
6.5.3. Mexico
7. Europe Vitamin D Therapy Market Size and Forecast (by Value USD Million)
7.1. Europe Vitamin D Therapy Market Size and Forecast, By Route of Administration (2023-2030)
7.2. Europe Vitamin D Therapy Market Size and Forecast, By Purchasing Pattern (2023-2030)
7.3. Europe Vitamin D Therapy Market Size and Forecast, By Application (2023-2030)
7.4. Europe Vitamin D Therapy Market Size and Forecast, By Age Group (2023-2030)
7.5. Europe Vitamin D Therapy Market Size and Forecast, by Country (2023-2030)
7.5.1. UK
7.5.2. France
7.5.3. Germany
7.5.4. Italy
7.5.5. Spain
7.5.6. Sweden
7.5.7. Austria
7.5.8. Rest of Europe
8. Asia Pacific Vitamin D Therapy Market Size and Forecast (by Value USD Million)
8.1. Asia Pacific Vitamin D Therapy Market Size and Forecast, By Route of Administration (2023-2030)
8.2. Asia Pacific Vitamin D Therapy Market Size and Forecast, By Purchasing Pattern (2023-2030)
8.3. Asia Pacific Vitamin D Therapy Market Size and Forecast, By Application (2023-2030)
8.4. Asia Pacific Vitamin D Therapy Market Size and Forecast, By Age Group (2023-2030)
8.5. Asia Pacific Vitamin D Therapy Market Size and Forecast, by Country (2023-2030)
8.5.1. China
8.5.2. S Korea
8.5.3. Japan
8.5.4. India
8.5.5. Australia
8.5.6. Indonesia
8.5.7. Malaysia
8.5.8. Vietnam
8.5.9. Taiwan
8.5.10. Bangladesh
8.5.11. Pakistan
8.5.12. Rest of Asia Pacific
9. Middle East and Africa Vitamin D Therapy Market Size and Forecast (by Value USD Million)
9.1. Middle East and Africa Vitamin D Therapy Market Size and Forecast, By Route of Administration (2023-2030)
9.2. Middle East and Africa Vitamin D Therapy Market Size and Forecast, By Purchasing Pattern (2023-2030)
9.3. Middle East and Africa Vitamin D Therapy Market Size and Forecast, By Application (2023-2030)
9.4. Middle East and Africa Vitamin D Therapy Market Size and Forecast, By Age Group (2023-2030)
9.5. Middle East and Africa Vitamin D Therapy Market Size and Forecast, by Country (2023-2030)
9.5.1. South Africa
9.5.2. GCC
9.5.3. Egypt
9.5.4. Nigeria
9.5.5. Rest of ME&A
10. South America Vitamin D Therapy Market Size and Forecast (by Value USD Million)
10.1. South America Vitamin D Therapy Market Size and Forecast, By Route of Administration (2023-2030)
10.2. South America Vitamin D Therapy Market Size and Forecast, By Purchasing Pattern (2023-2030)
10.3. South America Vitamin D Therapy Market Size and Forecast, By Application (2023-2030)
10.4. South America Vitamin D Therapy Market Size and Forecast, By Age Group (2023-2030)
10.5. South America Vitamin D Therapy Market Size and Forecast, by Country (2023-2030)
10.5.1. Brazil
10.5.2. Argentina
10.5.3. Rest of South America
11. Company Profile: Key players
11.1. Abbott
11.1.1. Overview
11.1.2. Business Segment
11.1.3. Financial Overview
11.1.3.1. Total Revenue
11.1.3.2. Segment Revenue
11.1.3.3. Regional Revenue
11.1.4. SWOT Analysis
11.1.5. Strategic Analysis
11.1.6. Recent Developments
11.2. Sanofi
11.3. GlaxoSmithKline plc
11.4. Pfizer Inc.
11.5. Merck & Co., Inc.
11.6. Torrent Pharmaceuticals Ltd.
11.7. Novartis International AG
11.8. Alkem Laboratories
11.9. Sun Pharmaceutical Industries Ltd.
11.10. Cadila Healthcare Ltd
11.11. AIE Pharmaceuticals
11.12. Tru Body Wellness
11.13. Matsun Nutrition
11.14. NewGen Pharma
12. Key Findings
13. Industry Recommendations
13.1. Strategic Recommendations
13.2. Future Outlook
